Yabing Guo
Nanfang Hospital(CN)Southern Medical University(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study(2021)1,051 cited
- → Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)(2023)404 cited
- → aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis(2020)331 cited
- → Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies(2003)168 cited
- → ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China(2020)111 cited
- → Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients(2021)80 cited